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Hypertension is a modifiable risk factor for cardiovascular disease (CVD). Diet 
intervention by increasing the intake of fruits and vegetables proved to be 
beneficial by reducing blood pressure (BP) and lowering the risk of CVD. Apart from 
micronutrients, the phytochemical content of fruits and vegetables has been 
associated with the BP lowering effect. Hypertension is commonly associated with a 
reduced vascular nitric oxide (NO) due to excessive degradation by reactive oxygen 
species (ROS). In addition, NO is also important in maintaining organ functions and 
perfusion. In this study normal and NO deficient rats were used to evaluate the BP 
lowering effect and antioxidative property of oil palm frond methanolic extract 
(OPFME). The protective effect of OPFME in the liver, heart, kidney and brain of 
these rats were assessed and any toxicity effect was also investigated. Two major 
groups of rats (normal and NO deficient groups) were further divided into three 
sub-groups; the first subgroup received the vehicle used to dilute OPFME; the 
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second subgroup received OPFME and the third subgroup received captopril. NO 
deficiency was induced by administration of N-ω-nitro-L-arginine methyl ester (L-
NAME). Erythrocyte/organ superoxide dismutase (SOD), catalase and glutahione 
peroxidase (GPx) activities, and plasma/organ malondialdehyde (MDA) 
concentration were measured. Livers, hearts, kidneys and brains were removed at 
the end of the study. Histological appearances of these organs were examined. 
Kidneys were functionally evaluated by measurement of plasma creatinine and urea 
concentrations, whereas liver function was tested by measuring plasma alanine 
aminotransferase (ALT), aspartate aminotransfersa (AST), and alkaline phosphatase 
(ALP). OPFME significantly attenuated BP increases in NO deficient rats comparable 
to captopril, and temporarily improved antioxidant status. In the liver OPFME 
partially protected hepatocytes from extensive injury due to NO deficiency. OPFME 
also partially prevented coronary arterioles from thickening, but failed to inhibit 
structural changes in the left ventricle. The glomeruli of OPFME treated NO 
deficient rats were not improved. Slight renal tubular dilation observed in normal 
rats treated with OPFME is a matter of concern and should be further investigated. 
OPFME showed remarkable hippocampal neuroprotection and this correlated well 
with its antioxidative property in the brain. There was no neurotoxic effect of 
OPFME observed. On the contrary, neurogenesis was displayed as an increase in the 
number of viable granule cells of the dentate gyrus (DG) of normal rats treated with 
OPFME. In conclusion, OPFME was effective in suppressing BP increment during NO 
deficiency. The extract was also partially hepatoprotective and significantly 
neuroprotective. However, OPFME may induce nephrotoxicity and should be 
investigated further for clarification.  
v 
 
Abstrak tesis yang dikemukan kepada Senat Universiti Putra Malaysia sebagai 
memenuhi keperluan untuk ijazah Doktor Falsafah. 
 
KESAN EKSTRAK METHANOL DAUN KELAPA SAWIT TERHADAP TEKANAN DARAH, 
TAHAP ANTIOKSIDAN DAN ORGAN TERPILIH PADA TIKUS KEKURANGAN NITRIK 
OKSIDA 
 
Oleh 
JULIANA BT MD JAFFRI 
Viva Voce: Mei 2009 
 
Pengerusi: Professor Dr Suhaila Bt Mohamed 
Fakulti: Sains dan Teknologi Makanan  
 
Hipertensi adalah factor risiko penyakit kardiovaskular yang boleh diatasi. 
Pengubahsuaian cara pemakanan dengan melebihkan buah-buahan dan sayur-
sayuran telah terbukti dapat mengurangkan tekanan darah serta mengurangkan 
risiko penyakit kardiovaskular. Selain dari zat-zat makanan asas, kandungan 
polifenol buah-buahan dan sayur-sayuran juga dikaitkan dengan penurunan 
tekanan darah. Hipertensi adalah penyakit yang sering dikaitkan dengan penurunan 
kandungan nitrik oksida vaskular akibat tindakbalas radikal oksigen yang tidak 
terkawal. Nitrik oksida juga adalah penting untuk fungsi dan pengaliran darah ke 
organ-organ badan. Kajian ini dijalankan untuk menilai kesan ekstrak daun kelapa 
sawit terhadap penurunan tekanan darah dan tahap antioksidan badan. Kesan-
kesan terhadap hati, ginjal, jantung dan otak juga dikaji untuk menentukan tahap 
perlindungan dari kegagalan yang berpunca dari kekurangan nitrik oksida. Selain 
daripada itu pemerhatian terhadap kesan-kesan toksik ekstrak daun kelapa sawit 
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juga dijalankan. Tikus digunakan untuk kajian ini, dan telah dibahagikan kepada dua 
kumpulan utama iaitu normal dan kekurangan nitrik oksida. Setiap kumpulan 
dibahagikan kepada tiga kumpulan kecil mengikut rawatan yang diberikan. 
Kumpulan pertama menerima pelarut yang digunakan untuk melarutkan ekstrak, 
kumpulan kedua menerima ekstrak dan kumpulan ketiga menerima captopril. Kesan 
kekurangan nitrik oksida dihasilkan daripada pemberian N-ω-nitro-L-arginine 
methyl ester (L-NAME). Tahap aktiviti superoxide dismutase (SOD), catalase dan 
glutahione peroxidase (GPx) dalam sel darah merah/organ serta kandungan 
malondialdehyde plasma/organ dikaji. Organ-organ yang dipilih untuk dikaji adalah 
hati, ginjal, jantung dan otak. Kajian histologi dilakukan ke atas  organ-organ 
tersebut. Tahap creatinine plasma dan urea dilakukan untuk menentukan fungsi 
ginjal, manakala kandungan alanine aminotransferase (ALT), aspartate 
aminotransfersa (AST), dan alkaline phosphatase (ALP) dilakukan untuk 
menentukan fungsi hati.   Ekstrak daun kelapa sawit didapati berkesan mengekalkan 
tekanan darah normal. Tahap antioksidan juga bertambah baik dengan 
pengambilan ekstrak walaupun tidak kekal hingga ke akhir tempoh kajian. Ekstrak 
tersebut juga didapati meredakan kerosakan sel hati yang teruk akibat kekurangan 
nitrik oksida, serta mengurangkan (tidak ketara) penebalan salur darah koronari 
tetapi tidak berkesan merencat perubahan struktur pada ventrikel kiri jantung.Tiada 
kesan perlindungan diperhatikan di glomerulus. Ekstrak didapati menyebabkan 
sedikit pembengkakan pada tiub ginjal, dan ianya perlu dikaji dengan lebih lanjut. 
Kesan ekstrak pada sel-sel otak di hippocampus adalah sangat baik di mana ianya 
mungkin disebabkan oleh peningkatan tahap antioksidan otak. Tiada kesan 
sampingan berlaku di organ ini akibat rawatan ekstrak, malah di bahagian dentate 
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gyrus sel-sel neuron didapati bertambah bilangannya. Kesimpulannya, ekstrak daun 
kelapa sawit berkesan mengawal peningkatan tekanan darah semasa di dalam 
keadaan kekurangan nitrik oksida. Ekstrak juga mengurangkan kegagalan hati (tidak 
ketara), serta dapat melindungi dari kerosakan sel-sel otak. Walau bagaimana pun 
ekstrak mungkin boleh menyebabkan kesan toksik di ginjal. Oleh itu, kajian lanjut 
perlu dijalankan untuk menjelaskan masalah ini. 
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CHAPTER 1 
 
INTRODUCTION 
 
Hypertension is a lifestyle related disease which can be devastating if complicated. 
It is a common risk factor for CVD (Schnall et al, 2000; Grundy et al, 1999), affecting 
millions of people throughout the world and in 2006 about 43% of the adult 
Malaysian population (30 years and above) have diastolic blood pressure of 90 
mmHg or greater, a relative increase of 30% from that of 10 years earlier (Ministry 
of Health, 2008).  
 
There is still much uncertainty about the pathophysiology of hypertension. 
Decreased level of NO, a very important mediator of vasorelaxation, is a well known 
factor for increased blood pressure (Forte et al, 1997). This condition is also 
associated with obesity/insulin resistance, whereby obese/insulin-resistant subjects 
are characterized by endothelial dysfunction and endothelial resistance to insulin's 
effect on enhancement of endothelium-dependent vasodilation (Steinberg et al, 
1996). The low NO level could contribute to the development of hypertension. 
Epidemiological studies indicate that two major determinants of human morbidity 
and mortality, arterial hypertension and insulin resistance, are related, suggesting 
the possibility of a common underlying mechanism (Duplain et al, 2001; Modan et 
al, 1985; Lucas et al, 1985). 
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CVD development is a multi-factorial process in which endothelial dysfunction, 
inflammatory response, dyslipidemia, and activated platelets all play significant role 
in the process (Hansson, 2005; Libby and Simon, 2001). The seriousness of the 
Malaysian situation has prompted The Ministry of Health to launch a number of 
campaigns in an effort to prevent CVD from becoming widespread. As the rising 
number of individuals with hypertension are identified and treated, the incremental 
burden on the Malaysian government healthcare system could be staggering.  
 
A nutritional approach to this problem would be especially appealing, because it 
could minimize both the healthcare workload and the cost of therapy. In addition, 
nutritional approach rarely results in unwanted side effects, which is very common 
with most pharmacological therapy. Based on the Dietary Approach to Stop 
Hypertension (DASH) diet (Most et al, 2004), the intake of plant foods high in 
phytochemicals is associated with lowering of BP. An alternative way of increasing 
phytochemical intake is through supplementation with plant based nutraceuticals, 
in a convenient capsule/tablet form that is compact and easy to take. Individuals 
with strong family history of obesity and metabolic syndrome may benefit from this 
approach, as the problem is usually dealt with at an early stage, whereby it is still 
uncomplicated and reversal of the condition is possible. Oil palm frond extract may 
be a good candidate for a nutraceutical in this category, which may help reduce the 
risk of developing hypertension in individuals with low endothelial NO.    
 
The majority of nutraceuticals in Malaysia is imported from countries such as USA 
and Australia, utilizing plants from the temperate climate. This is one of the reasons 
